William Pridgen - Net Worth and Insider Trading

William Pridgen Net Worth

The estimated net worth of William Pridgen is at least $197,933 dollars as of 2024-06-05. William Pridgen is the Director of Virios Therapeutics Inc and owns about 761,279 shares of Virios Therapeutics Inc (VIRI) stock worth over $197,933. Details can be seen in William Pridgen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William Pridgen has not made any transactions after 2023-08-21 and currently still holds the listed stock(s).

Transaction Summary of William Pridgen

To

William Pridgen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William Pridgen owns 1 companies in total, including Virios Therapeutics Inc (VIRI) .

Click here to see the complete history of William Pridgen’s form 4 insider trades.

Insider Ownership Summary of William Pridgen

Ticker Comapny Transaction Date Type of Owner
VIRI Virios Therapeutics Inc 2023-08-21 director

William Pridgen Latest Holdings Summary

William Pridgen currently owns a total of 1 stock. William Pridgen owns 761,279 shares of Virios Therapeutics Inc (VIRI) as of August 21, 2023, with a value of $197,933.

Latest Holdings of William Pridgen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VIRI Virios Therapeutics Inc 2023-08-21 761,279 0.26 197,933

Holding Weightings of William Pridgen


William Pridgen Form 4 Trading Tracker

According to the SEC Form 4 filings, William Pridgen has made a total of 9 transactions in Virios Therapeutics Inc (VIRI) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Virios Therapeutics Inc is the acquisition of 15,335 shares on August 21, 2023, which cost William Pridgen around $19,936.

Insider Trading History of William Pridgen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William Pridgen Trading Performance

GuruFocus tracks the stock performance after each of William Pridgen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Pridgen is -20.44%. GuruFocus also compares William Pridgen's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Pridgen within 3 months outperforms 3 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how William Pridgen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of William Pridgen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15.43 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -12.91 LIMIT LIMIT LIMIT LIMIT LIMIT

William Pridgen Ownership Network

Ownership Network List of William Pridgen

No Data

Ownership Network Relation of William Pridgen

Insider Network Chart

William Pridgen Owned Company Details

What does Virios Therapeutics Inc do?

Who are the key executives at Virios Therapeutics Inc?

William Pridgen is the director of Virios Therapeutics Inc. Other key executives at Virios Therapeutics Inc include director & Chief Executive Officer Gregory Scott Duncan , VP of Finance Angela Walsh , and Vice President of Operations Ralph Grosswald .

Virios Therapeutics Inc (VIRI) Insider Trades Summary

Over the past 18 months, William Pridgen made 1 insider transaction in Virios Therapeutics Inc (VIRI) with a net purchase of 15,335. Other recent insider transactions involving Virios Therapeutics Inc (VIRI) include a net purchase of 25,000 shares made by Gregory Scott Duncan , a net sale of 1,800 shares made by Richard James Whitley ,

In summary, during the past 3 months, insiders sold 0 shares of Virios Therapeutics Inc (VIRI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,800 shares of Virios Therapeutics Inc (VIRI) were sold and 40,335 shares were bought by its insiders, resulting in a net purchase of 38,535 shares.

Virios Therapeutics Inc (VIRI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Virios Therapeutics Inc Insider Transactions

No Available Data

William Pridgen Mailing Address

Above is the net worth, insider trading, and ownership report for William Pridgen. You might contact William Pridgen via mailing address: 44 Milton Avenue, Alpharetta Ga 30009.

Discussions on William Pridgen

No discussions yet.